Potential conflict of interest: Dr. Tyrrell owns stock in and holds intellectual property rights with KMT Hepatech.
Version of Record online: 12 DEC 2012
Copyright © 2012 American Association for the Study of Liver Diseases
Volume 57, Issue 2, pages 461–469, February 2013
How to Cite
Wilkins, C., Woodward, J., Lau, D. T.-Y., Barnes, A., Joyce, M., McFarlane, N., McKeating, J. A., Tyrrell, D. L. and Gale, M. (2013), IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology, 57: 461–469. doi: 10.1002/hep.26066
This work was supported by National Institutes of Health grants AI060389, AI40035, and DA024563 (to M. G.) and DK068598-01 (to D. T.-Y. L.) and the Burroughs Wellcome Fund (M. G.).
- Issue online: 5 FEB 2013
- Version of Record online: 12 DEC 2012
- Accepted manuscript online: 19 SEP 2012 11:32AM EST
- Manuscript Accepted: 14 AUG 2012
- Manuscript Received: 22 MAR 2012
Additional Supporting Information may be found in the online version of this article.
|HEP_26066_sm_SuppFig1.tif||7678K||Supporting Information Figure 1.|
|HEP_26066_sm_SuppFig2.tif||2251K||Supporting Information Figure 2.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.